Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06706336

Radon Asthma Intervention Trial

To determine if radon mitigation can improve asthma

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

About this study

We will conduct a randomized, double-blind, sham controlled trial to investigate the efficacy of radon mitigation in the homes of susceptible individuals to provide evidence for health benefits by improving indoor air quality. The trial will include 180 children with asthma. We will install a standard radon specific mitigation system in the participant's home. Health outcomes will be followed over 48 weeks to determine the outcomes of the intervention versus inactive (sham) control.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

  • Have physician-diagnosed asthma at least 1 year prior to the screening visit
  • Have evidence of uncontrolled disease as defined by at least one of the following:

Use of an asthma medication during the prior 12 months, report of asthma symptoms over the prior 12 months (wheezing/whistling in the chest)(3)

OR

One or more asthma-related hospitalization, emergency room visit

OR

Unscheduled clinic or urgent care facility visit resulting in a burst of systemic steroids (3 days or more of prednisone or equivalent; 1 or more doses of dexamethasone) in the previous 12 months

Exclusion criteria

  • Not residing at the household for at least 5 days a week or family planning to move from the current home within the next twelve months, or homes with active radon mitigation systems (if home uses a HEPA filter air purifier, family must agree to disable the purifier for 28 days prior to randomization).
  • Lung disease, other than asthma, that requires daily medication (inflammatory diseases, chronic lung diseases aside from asthma, congenital cardiopulmonary conditions requiring medication or surgical treatment),
  • Homes with active HEPA filters will be excluded (even though the role of HEPA filters on radon and radon particles s is expected to be minimum and other exposures can be adjust for in the analysis)
  • Cardiovascular disease that requires daily medication, excluding hypertension
  • Taking a beta-blocker
  • Currently receiving unstable level of Immunotherapy (allergy shots)
  • Coordinator/PI judgment
  • Inability to perform lung function testing
  • Intake of abuse drugs or alcohol, have psychiatric disorders or severe mental disability that interferes with answering questions or following instructions.

Treatment and study plan

radon mitigation system

Other

standard radon mitigation system used to reduce radon in homes

Sham (No Treatment)

Other

inactive radon mitigation system

Primary outcomes

  1. Asthma symptoms

    Time frame: past 2 weeks

    Number of Days With Asthma Symptoms

Study contacts

Contact information is provided by the study sponsor or research team.

Wanda Phipatanakul

CONTACT

[email protected]

857-218-5336

Sponsors and collaborators

Lead sponsor

Boston Children's Hospital

Other

Registry information

Acronym: ROME

Important dates

Study start
2026
Primary completion
2029
Study completion
2030
First posted
Nov 26, 2024
Registry last updated
Feb 11, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.